There are 398 resources available
Introduction and first vote
Presenter: David Cameron
Session: Can we decrease chemotherapy in LN+ premenopausal women based on genomic tests?
Resources:
Slides
Webcast
165MO - Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial
Presenter: Rupert Bartsch
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Yes
Presenter: Janice Wing-Hang Tsang
Session: Can we decrease chemotherapy in LN+ premenopausal women based on genomic tests?
Resources:
Slides
Webcast
166MO - Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): initial results from BEGONIA, a phase 1b/2 study
Presenter: Peter Schmid
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
167MO - Association between ER, PR and HER2 levels and outcome under palbociclib (Pal) + aromatase inhibitors (AIs) as first-line therapy for ER+ HER2- metastatic breast cancer (MBC): An exploratory analysis of the PADA-1 trial
Presenter: Thibault de La Motte Rouge
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Second vote and conclusions
Presenter: David Cameron
Session: Can we decrease chemotherapy in LN+ premenopausal women based on genomic tests?
Resources:
Slides
Webcast
Invited Discussant LBA4, 165MO, 166MO and 167MO
Presenter: Ana Mafalda Antunes De Melo e Oliveira
Session: Mini Oral session 2
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini Oral session 2
Resources:
Webcast
A comprehensive biobehavioral approach to tackle toxicities and quality of life deterioration after breast cancer
Presenter: Antonio Di Meglio
Session: Major advances for breast cancer survivorship
Resources:
Slides
Webcast
How can we improve the first-line treatment of HER2+ mBC?
Presenter: Sara Hurvitz
Session: Treatment strategies for HER2+ metastatic breast cancer (mBC)
Resources:
Slides
Webcast